Latest AI and machine learning research in dementia for healthcare professionals.
Alzheimer's disease (AD) is a neurodegenerative disease with an irreversible and progressive process. To understand the brain functions and identify the biomarkers of AD and early stages of the disease [also known as, mild cognitive impairment (MCI)], it is crucial to build the brain functional connectivity network (BFCN) using resting-state functional magnetic resonance imaging (rs-fMRI). Existin...
The classification of Alzheimer's disease (AD) using deep learning methods has shown promising results, but successful application in clinical settings requires a combination of high accuracy, short processing time, and generalizability to various populations. In this study, we developed a convolutional neural network (CNN)-based AD classification algorithm using magnetic resonance imaging (MRI) s...
As the number of patients with Alzheimer's disease (AD) increases, the effort needed to care for these patients increases as well. At the same time, a...
Dementia of Alzheimer's type (DAT) is associated with devastating and irreversible cognitive decline. Predicting which patients with mild cognitive im...
As enzymes in the outer membrane of the mitochondrion, monoamine oxidases (MAOs) can catalyze the oxidative deamination of monoamines in the human bod...
Human evolution has regularly intersected with technology. Digitalization of various services has brought a paradigm shift in consumerism. Treading th...
Data collected from clinical trials and cohort studies, such as dementia studies, are often high-dimensional, censored, heterogeneous and contain miss...
Robotic seals have been studied in long-term care settings; though, no studies of patients with dementia in the acute care setting have been reported....
People with dementia often experience loneliness and social isolation. This can result in increased cognitive decline which, in turn, has a negative i...
BACKGROUND: The identification of early mild cognitive impairment (EMCI), which is an early stage of Alzheimer's disease (AD) and is associated with b...
BACKGROUND: SymptomGuide Dementia (DGI Clinical Inc) is a publicly available online symptom tracking tool to support caregivers of persons living with...
BACKGROUND AND PURPOSE: Limited evidence has suggested that a deep learning automatic brain segmentation and classification method, based on T1-weight...
BACKGROUND AND OBJECTIVES: Dementia is one of the brain diseases with serious symptoms such as memory loss, and thinking problems. According to the Wo...
Identifying the symptoms of the early stages of dementia is a difficult task, particularly for older adults living in residential care. Internet of Th...
As stroke mortality rates decrease, there has been a surge of effort to study poststroke dementia (PSD) to improve long-term quality of life for strok...
OBJECTIVE: This retrospective and exploratory study tested the accuracy of artificial neural networks (ANNs) at detecting Alzheimer's disease patients...
Cerebral Microbleeds (CMBs) are small chronic brain hemorrhages, which have been considered as diagnostic indicators for different cerebrovascular dis...
Subjective cognitive decline (SCD) is a high-risk yet less understood status before developing Alzheimer's disease (AD). This work included 76 SCD ind...
Mild cognitive impairment (MCI), an identified prodromal stage of Alzheimer's Disease (AD), often evades detection in the early stages of the conditio...
Recent advances in artificial intelligence and machine learning (ML) led to effective methods and tools for analyzing the human behavior. Human Activi...